Cargando…

Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice

BACKGROUND: Infections may be associated with exacerbation of allergic and autoimmune diseases. Paradoxically, epidemiological and experimental data have shown that some microorganisms can also prevent these pathologies. This observation is at the origin of the hygiene hypothesis according to which...

Descripción completa

Detalles Bibliográficos
Autores principales: Aumeunier, Aude, Grela, Françoise, Ramadan, Abdulraouf, Pham Van, Linh, Bardel, Emilie, Gomez Alcala, Alejandro, Jeannin, Pascale, Akira, Shizuo, Bach, Jean-François, Thieblemont, Nathalie
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900205/
https://www.ncbi.nlm.nih.gov/pubmed/20628601
http://dx.doi.org/10.1371/journal.pone.0011484
_version_ 1782183600967385088
author Aumeunier, Aude
Grela, Françoise
Ramadan, Abdulraouf
Pham Van, Linh
Bardel, Emilie
Gomez Alcala, Alejandro
Jeannin, Pascale
Akira, Shizuo
Bach, Jean-François
Thieblemont, Nathalie
author_facet Aumeunier, Aude
Grela, Françoise
Ramadan, Abdulraouf
Pham Van, Linh
Bardel, Emilie
Gomez Alcala, Alejandro
Jeannin, Pascale
Akira, Shizuo
Bach, Jean-François
Thieblemont, Nathalie
author_sort Aumeunier, Aude
collection PubMed
description BACKGROUND: Infections may be associated with exacerbation of allergic and autoimmune diseases. Paradoxically, epidemiological and experimental data have shown that some microorganisms can also prevent these pathologies. This observation is at the origin of the hygiene hypothesis according to which the decline of infections in western countries is at the origin of the increased incidence of both Th1-mediated autoimmune diseases and Th2-mediated allergic diseases over the last decades. We have tested whether Toll-like receptor (TLR) stimulation can recapitulate the protective effect of infectious agents on allergy and autoimmunity. METHODS AND FINDINGS: Here, we performed a systematic study of the disease-modifying effects of a set of natural or synthetic TLR agonists using two experimental models, ovalbumin (OVA)-induced asthma and spontaneous autoimmune diabetes, presenting the same genetic background of the non obese diabetic mouse (NOD) that is highly susceptible to both pathologies. In the same models, we also investigated the effect of probiotics. Additionally, we examined the effect of the genetic invalidation of MyD88 on the development of allergic asthma and spontaneous diabetes. We demonstrate that multiple TLR agonists prevent from both allergy and autoimmunity when administered parenterally. Probiotics which stimulate TLRs also protect from these two diseases. The physiological relevance of these findings is further suggested by the major acceleration of OVA-induced asthma in MyD88 invalidated mice. Our results strongly indicate that the TLR-mediated effects involve immunoregulatory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-β and different subsets of regulatory T cells, notably CD4(+)CD25(+)FoxP3(+) T cells for TLR4 agonists and NKT cells for TLR3 agonists. CONCLUSIONS/SIGNIFICANCE: These observations demonstrate that systemic administration of TLR ligands can suppress both allergic and autoimmune responses. They provide a plausible explanation for the hygiene hypothesis. They also open new therapeutic perspectives for the prevention of these pathologies.
format Text
id pubmed-2900205
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29002052010-07-13 Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice Aumeunier, Aude Grela, Françoise Ramadan, Abdulraouf Pham Van, Linh Bardel, Emilie Gomez Alcala, Alejandro Jeannin, Pascale Akira, Shizuo Bach, Jean-François Thieblemont, Nathalie PLoS One Research Article BACKGROUND: Infections may be associated with exacerbation of allergic and autoimmune diseases. Paradoxically, epidemiological and experimental data have shown that some microorganisms can also prevent these pathologies. This observation is at the origin of the hygiene hypothesis according to which the decline of infections in western countries is at the origin of the increased incidence of both Th1-mediated autoimmune diseases and Th2-mediated allergic diseases over the last decades. We have tested whether Toll-like receptor (TLR) stimulation can recapitulate the protective effect of infectious agents on allergy and autoimmunity. METHODS AND FINDINGS: Here, we performed a systematic study of the disease-modifying effects of a set of natural or synthetic TLR agonists using two experimental models, ovalbumin (OVA)-induced asthma and spontaneous autoimmune diabetes, presenting the same genetic background of the non obese diabetic mouse (NOD) that is highly susceptible to both pathologies. In the same models, we also investigated the effect of probiotics. Additionally, we examined the effect of the genetic invalidation of MyD88 on the development of allergic asthma and spontaneous diabetes. We demonstrate that multiple TLR agonists prevent from both allergy and autoimmunity when administered parenterally. Probiotics which stimulate TLRs also protect from these two diseases. The physiological relevance of these findings is further suggested by the major acceleration of OVA-induced asthma in MyD88 invalidated mice. Our results strongly indicate that the TLR-mediated effects involve immunoregulatory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-β and different subsets of regulatory T cells, notably CD4(+)CD25(+)FoxP3(+) T cells for TLR4 agonists and NKT cells for TLR3 agonists. CONCLUSIONS/SIGNIFICANCE: These observations demonstrate that systemic administration of TLR ligands can suppress both allergic and autoimmune responses. They provide a plausible explanation for the hygiene hypothesis. They also open new therapeutic perspectives for the prevention of these pathologies. Public Library of Science 2010-07-07 /pmc/articles/PMC2900205/ /pubmed/20628601 http://dx.doi.org/10.1371/journal.pone.0011484 Text en Aumeunier et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Aumeunier, Aude
Grela, Françoise
Ramadan, Abdulraouf
Pham Van, Linh
Bardel, Emilie
Gomez Alcala, Alejandro
Jeannin, Pascale
Akira, Shizuo
Bach, Jean-François
Thieblemont, Nathalie
Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
title Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
title_full Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
title_fullStr Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
title_full_unstemmed Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
title_short Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
title_sort systemic toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in nod mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900205/
https://www.ncbi.nlm.nih.gov/pubmed/20628601
http://dx.doi.org/10.1371/journal.pone.0011484
work_keys_str_mv AT aumeunieraude systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT grelafrancoise systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT ramadanabdulraouf systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT phamvanlinh systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT bardelemilie systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT gomezalcalaalejandro systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT jeanninpascale systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT akirashizuo systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT bachjeanfrancois systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice
AT thieblemontnathalie systemictolllikereceptorstimulationsuppressesexperimentalallergicasthmaandautoimmunediabetesinnodmice